Indication for a Pneumocystis Prophylaxis Therapy in Patients with Vascular Anomalies Treated with PIK3/AKT/mTOR Pathway Inhibitors: Experts' Opinion and Systematic Review from the Literature.
Dermatology
; 239(6): 942-951, 2023.
Article
in En
| MEDLINE
| ID: mdl-37793356
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pneumocystis
/
Pneumonia, Pneumocystis
/
Pneumocystis carinii
Type of study:
Qualitative_research
/
Risk_factors_studies
/
Systematic_reviews
Limits:
Child
/
Humans
Language:
En
Journal:
Dermatology
Journal subject:
DERMATOLOGIA
Year:
2023
Document type:
Article
Affiliation country:
France